Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices
Award Notice Posted
- Solicitation number
- BAA-75N93022R00021
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Sri International
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93024C00006 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Menlo Park, California 94025, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases has awarded SRI International a non-severable cost plus fixed fee completion type contract with non-severable options under the Broad Agency Announcement for the "Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices". The awarded contract amount is $6,607,920 for the development of medical countermeasures and biodosimetry devices to detect and treat exposure to radiation and nuclear materials.
Notice text
The National Insitute of Allergy and Infectious Diseases has awarded a non-severable cost plus fixed fee completion type contract with non-severable Options under the Broad Agency Announcement, titled "Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices".
Awarded contract 75N93024C00006 to SRI INTERNATIONAL for 6607920.00 on 2024-02-29.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices | Award Notice | |
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices | Solicitation | |
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity